Search

everythinglearnresearchcommunity

for

Search:↓

Chinese patients with systemic lupus erythematosus commonly experience oral ulcers, arthritis, alopecia, skin rash, and nephritis.

Methotrexate treatment for rheumatoid arthritis has a serious infection rate of about two per 100 patient-years.

Tofacitinib, a medication for arthritis, showed potential for treating severe hair loss in a small Brazilian case series, but more research is needed.

The care model improved timely diagnosis and treatment for psoriasis and psoriatic arthritis.

Tofacitinib improved arthritis and partially improved hair loss in a lupus patient without side effects.

A patient lost all their hair while on rheumatoid arthritis medication.

Targeting CD200 could be a new treatment for rheumatoid arthritis.

A woman with rheumatoid arthritis had a unique type of scarring hair loss not caused by infection, requiring early treatment to avoid permanent hair loss.

Most skin rashes in rheumatoid arthritis patients were not caused by their medication, and careful evaluation allowed most to keep taking their beneficial treatment.

Brodalumab effectively treated a man's severe hand and foot psoriasis.

The drug Olumiant is now approved to treat severe hair loss from alopecia and can also be used for some hospitalized COVID-19 patients.

Oral tofacitinib successfully treated total body hair loss in one patient.

Tofacitinib is a promising treatment for children with rheumatic diseases.

Upadacitinib effectively treated a patient with multiple inflammatory conditions.

PDE inhibitors, especially PDE4 inhibitors like apremilast, are effective for certain inflammatory skin conditions but have side effects and can be costly.

Managing multiple autoimmune diseases in one patient is very challenging.

Getting insurance to cover the hair loss treatment tofacitinib is hard because it's not officially approved for that use.

Etanercept improved symptoms of a specific type of psoriatic arthritis in a patient who didn't respond to other treatments.

An arthritis drug helped a person with severe hair loss regrow their hair.

Costovertebral arthritis can cause chronic back pain in SLE patients and needs thorough evaluation.

Upadacitinib significantly improved both rheumatoid arthritis and alopecia areata in a patient.

A woman got a serious strep infection from an IUD, likely passed from her husband's infected throat during sexual activity.

Certain immune system genes are linked to a higher risk of psoriasis and psoriatic arthritis, while others may offer protection.

Co-trimoxazole may help treat autoimmune diseases.

Baricitinib helps treat several diseases, including COVID-19, but has side effects and needs careful monitoring.

JAK inhibitors may become the first approved treatment for alopecia areata if they are proven safe and effective.

Baricitinib might help treat hair loss in lupus patients, but more research is needed.

A woman's vitiligo improved with tofacitinib treatment, and her skin color remained even after stopping the medication, but there are concerns about cancer risk.

A man with severe hair loss saw hair and nail improvement after 10 months on tofacitinib without side effects.

Janus kinase inhibitors are promising drugs for treating autoimmune and inflammatory diseases.